71 signals · alpha_vantage, bluesky, h1b_lca +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Vertex Pharmaceuticals in the Pharmaceuticals / CFTR space registers relatively low workforce stress signals and low overall risk indicators based on 4 signals across 2 sources.
Signals for Vertex Pharmaceuticals were collected from 2 sources. Aggregate signal sentiment appears broadly positive. The stress score stands at 27/100 with a risk score of 0/100. Signal coverage is sufficient to support a preliminary assessment.
What this means
Signals indicate a relatively stable workplace environment based on available data.
AI-generated from public signals — may be incomplete.
Reshma Kewalramani was born in Bombay and moved to the US at age 11. In 2020, she became the first woman to lead a large public biotech company. Vertex Pharmaceuticals posted $12.0 billion in revenue in 2025 under her leadership, up 9% year-over-year. #Bharat100 #IndianDiaspora #GreatImmigrants
Vertex Pharmaceuticals posted $12.0 billion in revenue in 2025 under her leadership, up 9% year-over-year.
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher Yahoo Finance
Biotechnology focused on cystic fibrosis and beyond.
Based on 71 signals across 4 sources · snapshot 16 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Vertex Pharmaceuticals is positive based on public signals as of 16 Sept 2026.
Based on 71 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher FXEmpire